Forge Biologics, Inc.
- Home
- Companies
- Forge Biologics, Inc.
- Products
- Advanced Technologies
Advanced Technologies
At Forge, our platform approach employs the triple plasmid transfection method – the industry-standard method for manufacturing AAV. This method is bolstered by Forge’s proprietary technologies, our Ignition Cells™ and pEMBR™ adenovirus helper plasmid.
- Clonal HEK293 mammalian suspension cell line
- Royalty-free license for clients
- Optimized for robust transient transfection
- Animal component free
- Scalable production
- Adenovirus Helper Plasmid
- Lower cost for production
- Improved safety profile – removed unnecessary adenoviral elements
- Forge Biologics intellectual property
- Available for pipeline use